88: Physicians Using a Computer Guidance System Based on KDOQI Guidelines Appear to Regulate Systolic Blood Pressure Around the Recommended Target of 130 mmHg
J. Ennis , J. Asplin , S. Donahue , E. Worcester
American Journal of Kidney Diseases 55 ( 4) B53
2010
87: Corrected Serum Calcium but not Phosphate Correlates With Change in Serum PTH in Treatment of Stages 3-5 CKD
J. Ennis , J. Asplin , S. Donahue , E. Worcester
American Journal of Kidney Diseases 55 ( 4) B53
2010
Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals.
J. Asplin , S. DeGanello , Y. N. Nakagawa , F. L. Coe
American Journal of Physiology-renal Physiology 261 ( 5)
28
1991
MEDICAL REDUCTION OF STONE RISK IN A NETWORK OF TREATMENT CENTERS COMPARED TO A RESEARCH CLINIC
J. LINGEMAN , H. MARDIS , R. KAHNOSKI , D.S. GOLDFARB
The Journal of Urology 160 ( 5) 1629 -1634
28
1998
DIVERGENCE BETWEEN STONE COMPOSITION AND URINE SUPERSATURATION: CLINICAL AND LABORATORY IMPLICATIONS
J. LINGEMAN , R. KAHNOSKI , H. MARDIS , D.S. GOLDFARB
The Journal of Urology 161 ( 4) 1077 -1081
15
1999
METABOLIC URINARY CORRELATES OF CALCIUM OXALATE DIHYDRATE IN RENAL STONES
J. LINGEMAN , R. KAHNOSKI , H. MARDIS , J.H. PARKS
The Journal of Urology 159 ( 3) 664 -668
39
1998
SUPERSATURATION AND STONE COMPOSITION IN A NETWORK OF DISPERSED TREATMENT SITES
J. ASPLIN , J. PARKS , J. LINGEMAN , R. KAHNOSKI
The Journal of Urology 159 ( 6) 1821 -1825
59
1998
Low Sodium Diet Decreases Stone Formation in Genetic Hypercalciuric Stone-Forming Rats.
Nancy S. Krieger , Marc Grynpas , Amy VandenEynde , John R. Asplin
Nephron 142 ( 2) 147 -158
1
2019
A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: a new paradigm for clinical outcomes studies in nephrology.
Geoffrey A. BLOCK , Martha S. PERSKY , Markus KETTELER , Bryan KESTENBAUM
Hemodialysis International 13 ( 3) 360 -362
21
2009
Citrate containing beverage
David S Goldfarb , Brian EISNER , John ASPLIN , Marshall L Stoller
1
2021
Administrative Assistant
B Brisky , F Ali , JR Asplin , M Banks
2017
Effect of Two Sports Drinks on Urinary Lithogenicity Editorial Comment
JW Goodman , JR Asplin , DS Goldfarb
JOURNAL OF UROLOGY 181 ( 5) 2157 -2157
2009
Purification and characterization of a human urinary S100 immunogen as a potent inhibitor of calcium oxalate monohydrate crystal growth and aggregation
NS Pillay , JR Asplin , FL Coe
Urolithiasis 1996, Proc 8th Int Symp on Urolithiasi, Pak CYC, Millet The Printer, Inc, Dallas, TX 301 -302
1
1996
Pharmacology, metabolism and nutrition
R Bouillon , Endocrinol Metab Clin , C Briguori , G Marenzi
Am J Respir Crit Care Med 174 1319 -1326
2006
Chlorthalidone reduces urine calcium, calcium phosphate supersaturation and stone formation in genetic hypercalciuric stone forming rats
DA Bushinsky , SB Smith , FL Coe , JR Asplin
Journal of the American Society of Nephrology 14 49A -49A
2003
Effect of cystine-binding thiol capacity in patients drugs on urinary cystine with cystinuria
DJ Dolin , JR Asplin , L Flagel , M Grasso
JOURNAL OF ENDOUROLOGY 19 ( 3) 429 -432
2005
Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats
DA Bushinsky , K LaPlante , JR Asplin ,
Kidney International 69 ( 9) 1586 -1592
25
2006
Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats
DA Bushinsky , AC Michalenka , KL Strutz , S Donahue
Kidney international 73 ( 4) 423 -429
10
2007
Tubular disorders
JR Asplin , FL Coe
HARRISONS PRINCIPLES OF INTERNAL MEDICINE 16 ( 2) 1694 -1694
20
2005
Hereditary tubular disorders
JR Asplin , FL Coe
HARRISONS PRINCIPLES OF INTERNAL MEDICINE 1562 -1568
16
1998